Featured News

Our Partners

Latest News

TregTherapeutics Taps Eva Garland Consulting to Power Non-Dilutive Funding Strategy

Treg Therapeutics, a biotech developing therapies designed to restore immune tolerance, has announced a partnership with Eva Garland Consulting (EGC) to strengthen its non-dilutive funding strategy. The company is advancing its autoimmune tolerance platform and development programs, aiming for therapies that can restore immune tolerance rather than simply suppress the immune system. “For an emerging […]

Baltimore’s SereNeuro Therapeutics Closes Oversubscribed Pre-Seed Financing to Advance Non-Opioid Pain Pipeline 

SereNeuro Therapeutics, a preclinical-stage biotechnology company developing non-opioid therapies for pain, has announced today, the close of its oversubscribed pre-seed financing. The round advances the company’s lead program, SN101, toward Investigational New Drug (IND)-enabling activities and supports its second program, SN102. Qualifying investors structured their investments through Maryland’s Biotechnology Investment Incentive Tax Credit at the […]

Proof of Motion: What Investors Want

Investors from TEDCO and Blackbird Labs told Baltimore founders what really gets a deal moving. The short version: show your work, and keep showing it. I moderated the “What Investors Want” panel at the Fueling your Technology event hosted by ETC Baltimore. It was a very relevant discussion to lead since I am raising capital […]

North Carolina – Regional Life Sciences Roundup – October 02, 2026 

Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]

Durham’s Ramona Optics Closes $25M Series A Led by ARCH Venture Partners

Durham, North Carolina-based Ramona Optics, which develops imaging systems for biopharma and biomedical use, has closed an oversubscribed $25 million Series A financing round led by ARCH Venture Partners. Stealthpoint Ventures, ND Capital, Fall Line Capital, Hamamatsu Ventures, Dallas-based Murchison Capital Partners, and New York’s Overlap Holdings also participated. The round is Ramona’s first official […]

South Korea’s CorestemChemon Launches U.S. Operations in Winston-Salem’s Innovation Quarter

CorestemChemon, a biopharmaceutical company headquartered in South Korea, has begun U.S. operations based in Winston-Salem’s Innovation Quarter. Its U.S. subsidiary, CorestemChemon US Inc., currently has two executive-level employees in Winston-Salem, with plans to grow the team as its U.S. regulatory and clinical programs advance. The subsidiary is focused on U.S. commercialization of Neuronata-R, a stem […]

People on the Move: Andy Fenny Named President of Pace Life Sciences

Pace Life Sciences, the life sciences division of science and technology company Pace, has named Andrew (Andy) Fenny as its President.  “Pace Life Sciences has a strong foundation of scientific expertise, technical talent, and customer commitment,” said Fenny. “As life sciences organizations look for partners who can help deliver with speed and accuracy amidst evolving […]

UNC, NC State, and N.C. A&T Launch NIH-Funded C³ Program to Train the Next Generation of Drug Delivery Scientists

The UNC Eshelman School of Pharmacy has received funding from the National Institutes of Health to launch the C³ Drug Delivery Predoctoral Training Program. It’s a new cross-institutional T32 program designed to prepare the next generation of scientists to translate drug delivery innovations into real-world therapies. The program brings together UNC-Chapel Hill, North Carolina State […]

BioHealth Capital Region – Regional Life Sciences Roundup – October 2, 2026

Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]